Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Fentanyl Sandoz Fentanyl 2.1mg Transdermal patch Novartis New Zealand Limited Hexal AG, Holzkirchen, Germany
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Fentanyl Sandoz Fentanyl 4.2mg Transdermal patch Novartis New Zealand Limited Hexal AG, Holzkirchen, Germany
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Fentanyl Sandoz Fentanyl 6.3mg Transdermal patch Novartis New Zealand Limited Hexal AG, Holzkirchen, Germany
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Fentanyl Sandoz Fentanyl 8.4mg Transdermal patch Novartis New Zealand Limited Hexal AG, Holzkirchen, Germany
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Fentanyl Sandoz Fentanyl 12.6mg Transdermal patch Novartis New Zealand Limited Hexal AG, Holzkirchen, Germany
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Fentanyl Sandoz Fentanyl 16.8mg Transdermal patch Novartis New Zealand Limited Hexal AG, Holzkirchen, Germany
|
Dated this 8th day of January 2019.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).